Simple test predicts dangerous pregnancy disorder

October 22, 2019

Australian researchers have developed a way to predict the onset of a deadly pregnancy condition that kills 76,000 women and half a million babies each year, mostly in developing countries.

Researchers from Edith Cowan University in Perth Western Australia have developed a simple, low-cost way to predict preeclampsia, one of the leading causes of maternal-foetal mortality worldwide.

Preeclampsia can cause devastating complications for women and babies, including brain and liver injury in mothers and premature birth.

Survey gives early warning

ECU researchers assessed the health status of 593 pregnant Ghanaian women using the Suboptimal Health Questionnaire.

The Suboptimal Health Questionnaire was developed in 2009 by Professor Wei Wang from ECU's School of Health and Medical Sciences. Combining scores for fatigue, heart health, digestion, immunity and mental health, the questionnaire provides an overall 'suboptimal health score' that can help predict chronic diseases.

Professor Wang's PhD candidate Enoch Anto found that 61 per cent of women who scored high on the questionnaire went on to develop preeclampsia, compared with just 17 per cent of women who scored low.

When these results were combined with blood tests that measured women's calcium and magnesium levels, the researchers were able to accurately predict the development of preeclampsia in almost 80 per cent of cases.

Mr Anto said preeclampsia was very treatable once identified, so providing an early warning could save thousands of lives.

"In developing nations, preeclampsia is a leading cause of death for both mothers and babies. In Ghana, it's responsible for 18 per cent of maternal deaths," Mr Anto said.

"But it can be treated using medication that lowers blood pressure once diagnosed.

"Both blood tests for magnesium and calcium and the Suboptimal Health Questionnaire are inexpensive, making this ideally suited to the developing world where preeclampsia causes the most suffering."
-end-
'Integration of suboptimal health status evaluation as a criterion for prediction of preeclampsia is strongly recommended for healthcare management in pregnancy: a prospective cohort study in a Ghanaian population' was recently published in the EPMA Journal.

Edith Cowan University

Related Preeclampsia Articles from Brightsurf:

Brigham researchers make strides in detecting preeclampsia risk
To improve early detection of preeclampsia risks and better classify potential subtypes of the disease, a team led by researchers from Brigham and Women's Hospital analyzed an array of maternal and placental proteins, identifying several biomarkers that, from a blood sample drawn at 12 weeks gestation, can help predict the risk of preeclampsia and, equally importantly, can assess who may develop more severe forms of the condition.

Researchers found a link between genes and preeclampsia
Researchers have showed that HLA-G gene regulates male-to-female ratio at birth.

Novel biomarker discovery could lead to early diagnosis for deadly preeclampsia
Preeclampsia is a dangerous condition that worldwide kills over 70,000 women and 500,000 babies each year.

RNA molecules in maternal blood may predict pregnancies at risk for preeclampsia
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.

Review assesses stem cell therapy potential for treating preeclampsia
A review of using stem cells to treat preeclampsia, a dangerous condition in pregnancy, indicates that mesenchymal stem/stromal cells (MSCs), or their secreted vesicles, have the potential to be used as therapies that could progress to clinical trials.

Genetic signature may identify mothers at risk for preeclampsia
Researchers at Baylor College of Medicine have identified a genetic signature combining certain maternal and fetal gene variants that are associated with a higher risk of preeclampsia.

Women with preeclampsia may be at greater risk for cardiac conditions later in life
Women who have gestational hypertension or preeclampsia in at least one pregnancy will have higher cardiovascular risk than women without such a history, and that this elevated risk persists at least into their 60s.

Medication use during pregnancy is common in women with preeclampsia
Use of medications during pregnancy is more common in women with preeclampsia than in those without, according to a British Journal of Clinical Pharmacology analysis of women who gave birth at a hospital in Finland in 2002-2016.

Best strategy for managing hypertension and preeclampsia at end of pregnancy
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.

Narrowing risk of preeclampsia to a specific phenotype
In a recent paper in The Journal of Clinical Endocrinology & Metabolism, MUSC researchers look at preeclampsia when it coincides with type 1 diabetes.

Read More: Preeclampsia News and Preeclampsia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.